Rapidly progressive interstitial lung disease in patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis: serial changes on HRCT

Emerg Radiol. 2022 Dec;29(6):961-967. doi: 10.1007/s10140-022-02080-y. Epub 2022 Aug 2.

Abstract

Background: Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibodies in patients with dermatomyositis are associated with rapidly progressive interstitial lung disease (RP-ILD). Computed tomography (CT) plays a central role in the diagnosis of RP-ILD and may help characterize the temporal changes.

Methods: We report five anti-MDA5-positive dermatomyositis patients with serial CT scans spanning their acute RP-ILD disease course.

Results: Our case series highlights the variable imaging pattern that can manifest in this setting, including diffuse alveolar damage and nonspecific interstitial pneumonia patterns. Three patients in our series died within 4 months of their disease onset, whereas the other two patients survived.

Conclusion: The serial CT changes in anti-MDA5 disease are dynamic and variable; therefore, it is imperative to maintain a broad differential when faced with these HRCT patterns to improve the diagnosis and management of this underrecognized entity.

Keywords: Anti-melanoma differentiation; HRCT; Interstitial lung disease.

MeSH terms

  • Autoantibodies
  • Dermatomyositis* / complications
  • Dermatomyositis* / diagnostic imaging
  • Disease Progression
  • Humans
  • Interferon-Induced Helicase, IFIH1
  • Lung Diseases, Interstitial* / complications
  • Lung Diseases, Interstitial* / diagnostic imaging

Substances

  • Interferon-Induced Helicase, IFIH1
  • Autoantibodies